Title
Category
Credits
Event date
Cost
Opioid De-Escalation, Dr. Taylor Steuber
  • Opioid Training Institute
  • On-Demand
  • COACH
  • 1.20 ABN
  • 1.00 ABSWE
  • 1.00 ACPE Pharmacy
  • 1.00 Attendance
$0.00
This webinar addresses the complex topic of de-prescribing and tapering opioids. There is lack of formal guidance in this area yet there is a large push to taper patients off of opioids.The Opioid Training Institute is a cooperative effort of the Alabama Department of Mental Health and the Substance Abuse and Mental Health Services Administration. It is made possible by a grant provided by SAMHSA.
C.A.R.E.S. Article: Assistance Programs for Older Adults
  • ADSS Certified Aging Resource Educated Specialists (C.A.R.E.S.)
  • 1.20 ABN
  • 1.00 ABSWE
  • 1.00 ACPE Pharmacy
  • 1.00 ACPE Technician
  • 1.00 Attendance
$0.00
The C.A.R.E.S. continuing education programs are designed for Alabama pharmacists and pharmacy technicians to provide an overview of Medicare and the roles of the Aging and Disability Resource Centers (ADRCs) with the primary goal to help pharmacists and pharmacy staff effectively and efficiently assist Medicare beneficiaries. All of our CE programs are funded by the Alabama Department of Senior Services (ADSS) and the U.S. Administration for Community Living. They are made available to pharmacists and technicians in Alabama at no cost.
ALAHOPE Recorded Course - Multidisciplinary and Patient Centered Approach to Substance Use Disorder
  • ALAHOPE Substance Use
  • 0.30 ABN
  • 0.25 ABSWE
  • 0.25 ACPE Pharmacy
  • 0.25 AMA PRA Category 1 Credit™
  • 0.25 Attendance
  • 0.25 BDEA
$0.00
An interactive, online training session regarding the importance of taking a multidisciplinary, patient centered approach to substance use disorder treatment.
ALAHOPE Recorded Course - Substance Use in the US
  • ALAHOPE Substance Use
  • 0.30 ABN
  • 0.25 ABSWE
  • 0.25 ACPE Pharmacy
  • 0.25 AMA PRA Category 1 Credit™
  • 0.25 Attendance
  • 0.25 BDEA
$0.00
An interactive, online training session regarding the history, current state, and impact of substance use in the U.S. particularly focusing on opioid use and related polydrug use.
ALAHOPE Recorded Course - Harm Reduction
  • ALAHOPE Substance Use
  • 0.30 ABN
  • 0.25 ABSWE
  • 0.25 ACPE Pharmacy
  • 0.25 AMA PRA Category 1 Credit™
  • 0.25 Attendance
  • 0.25 BDEA
$0.00
An interactive, online training session regarding harm reduction techniques around opioid use and related polydrug use.
ALAHOPE Recorded Course - Stigma and Language
  • ALAHOPE Substance Use
  • 0.30 ABN
  • 0.25 ABSWE
  • 0.25 ACPE Pharmacy
  • 0.25 AMA PRA Category 1 Credit™
  • 0.25 Attendance
  • 0.25 BDEA
$0.00
An interactive, online training session regarding stigma issues and appropriate language around substance use disorder.
ALAHOPE Recorded Course - Patient Communication
  • ALAHOPE Substance Use
  • 0.30 ABN
  • 0.25 ABSWE
  • 0.25 ACPE Pharmacy
  • 0.25 AMA PRA Category 1 Credit™
  • 0.25 Attendance
  • 0.25 BDEA
$0.00
An interactive, online training session regarding how to communicate with patients that have substance use disorder.
ALAHOPE Recorded Course - Safe Tapering of Benzodiazepines
  • ALAHOPE Substance Use
  • 0.30 ABN
  • 0.25 ABSWE
  • 0.25 ACPE Pharmacy
  • 0.25 AMA PRA Category 1 Credit™
  • 0.25 Attendance
  • 0.25 BDEA
$0.00
An interactive, online training session regarding when and how to taper benzodiazepines.
ALAHOPE Recorded Course - Overdose Antidote Therapy
  • ALAHOPE Substance Use
  • 0.30 ABN
  • 0.25 ABSWE
  • 0.25 ACPE Pharmacy
  • 0.25 AMA PRA Category 1 Credit™
  • 0.25 Attendance
  • 0.25 BDEA
$0.00
An interactive, online training session regarding antidotes for responding to an overdose.
ALAHOPE Recorded Course - Neuromechanisms of Substance Use Disorder
  • ALAHOPE Substance Use
  • 0.30 ABN
  • 0.25 ABSWE
  • 0.25 ACPE Pharmacy
  • 0.25 AMA PRA Category 1 Credit™
  • 0.25 Attendance
  • 0.25 BDEA
$0.00
An interactive, online training session regarding the neurology and neurobiology components of substance use disorder along with explaining the similarities between substance use disorder and chronic disease.

Pages